Cohortias – Positive data from Alzheimer’s disease vaccine trial
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
ALTB-268 helps to restore the immune system to a state of balance.
The trial will enroll 44 patients who are failing prior lines of chemotherapy and who express LGR5 on cancer cells.
The trial will assess the efficacy and safety of pulsed inhaled nitric oxide in patients at risk for pulmonary hypertension.
The trial is expected to enroll subjects at 20 clinical sites in the US and will assess CYR-064 for six months.
Shingrix shingles vaccine was 90% effective in preventing viral infection in adults over 50 years of age
At the moment there's no known cure for it, but scientists have now identified a potentially effective treatment
The trial assessed the efficacy and safety of BXCL701 along with pembrolizumab in SCNC patients.
Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages.
The purpose of the meeting is to clarify technical doubts and have access to preliminary data.